Back to Search Start Over

Projected Colorectal Cancer Incidence and Mortality Based on Observed Adherence to Colonoscopy and Sequential Stool-Based Screening.

Authors :
Meester, Reinier G. S.
Lansdorp-Vogelaar, Iris
Winawer, Sidney J.
Church, Timothy R.
Allen, John I.
Feld, Andrew D.
Mills, Glenn
Jordan, Paul A.
Corley, Douglas A.
Doubeni, Chyke A.
Hahn, Anne I.
Lobaugh, Stephanie M.
Fleisher, Martin
O'Brien, Michael J.
Zauber, Ann G.
Source :
American Journal of Gastroenterology (Lippincott Williams & Wilkins). Jul2024, Vol. 119 Issue 7, p1392-1401. 10p.
Publication Year :
2024

Abstract

INTRODUCTION: Modeling supporting recommendations for colonoscopy and stool-based colorectal cancer (CRC) screening tests assumes 100% sequential participant adherence. The impact of observed adherence on the long-term effectiveness of screening is unknown. We evaluated the effectiveness of a program of screening colonoscopy every 10 years vs annual high-sensitivity guaiac-based fecal occult blood testing (HSgFOBT) using observed sequential adherence data. METHODS: The MIcrosimulation SCreening ANalysis (MISCAN) model used observed sequential screening adherence, HSgFOBT positivity, and diagnostic colonoscopy adherence inHSgFOBT-positive individuals from theNational Colonoscopy Study (single-screening colonoscopy vs ≥4HSgFOBT sequential rounds). We compared CRC incidence and mortality over 15 years with no screening or 10 yearly screening colonoscopy vs annual HSgFOBT with 100% and differential observed adherence from the trial. RESULTS: Without screening, simulated incidence and mortality over 15 years were 20.9 (95% probability interval 15.8-26.9) and 6.9 (5.0-9.2) per 1,000 participants, respectively. In the case of 100% adherence, only screening colonoscopy was predicted to result in lower incidence; however, both tests lowered simulated mortality to a similar level (2.1 [1.6-2.9] for screening colonoscopy and 2.5 [1.8-3.4] for HSgFOBT). Observed adherence for screening colonoscopy (83.6%) was higher than observed sequential HSgFOBT adherence (73.1% first round; 49.1% by round 4), resulting in lower simulated incidence and mortality for screening colonoscopy (14.4 [10.8-18.5] and 2.9 [2.1-3.9], respectively) than HSgFOBT (20.8 [15.8-28.1] and 3.9 [2.9-5.4], respectively), despite a 91% adherence to diagnostic colonoscopy with FOBT positivity. The relative risk of CRC mortality for screening colonoscopy vs HSgFOBT was 0.75 (95% probability interval 0.68-0.80). Findings were similar in sensitivity analyses with alternative assumptions for repeat colonoscopy, test performance, risk, age, and projection horizon. DISCUSSION: Where sequential adherence to stool-based screening is suboptimal and colonoscopy is accessible and acceptable--as observed in the national colonoscopy study, microsimulation, comparative effectiveness, screening recommendations. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00029270
Volume :
119
Issue :
7
Database :
Academic Search Index
Journal :
American Journal of Gastroenterology (Lippincott Williams & Wilkins)
Publication Type :
Academic Journal
Accession number :
178473798
Full Text :
https://doi.org/10.14309/ajg.0000000000002693